eXoZymes, Inc. (EXOZ)Healthcare | Biotechnology | Monrovia, United States | NasdaqCM
6.37 USD
-0.48
(-7.007%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 6.38 +0.01 (0.157%) ⇧ (July 13, 2026, 4:10 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 5:28 a.m. EDT
The immediate outlook is severely clouded by a relentless downward price trend and deteriorating financial health. Over the last two weeks, the stock has plummeted from $8.18 to $6.97, trading well below its 50-day and 200-day moving averages, which signals significant selling pressure and a lack of near-term support. This technical breakdown is compounded by a catastrophic fundamental reality: the company is burning cash aggressively with negative operating cash flow of nearly $7 million and negative free cash flow. The balance sheet is fragile, with debt exceeding cash reserves, and profitability is nonexistent, evidenced by negative returns on both assets and equity. While recent headlines mention capital raises, these are life-support measures rather than signs of organic growth, suggesting the business model is struggling to generate sustainable revenue. With no dividend to provide income and a trajectory pointing toward further dilution or distress, there is no compelling case for a short-term bounce or a long-term hold. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.139144 |
| AutoARIMA | 0.142478 |
| AutoETS | 0.146944 |
| MSTL | 0.165074 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 22% |
| H-stat | 27.95 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 1.46 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 76.231 |
| Market Cap | 59,122,256 |
| Previous Name | Invizyne Technologies, Inc. |
| Website | https://www.exozymes.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.2896453 |
| Address1 | 750 Royal Oaks Drive |
| Address2 | Suite 106 |
| All Time High | 23.99 |
| All Time Low | 6.33 |
| Ask | 7.41 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 21,510 |
| Average Daily Volume3 Month | 7,801 |
| Average Volume | 7,801 |
| Average Volume10Days | 21,510 |
| Bid | 8.2 |
| Bid Size | 9 |
| Book Value | 0.18 |
| City | Monrovia |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 6.37 |
| Current Ratio | 1.321 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 7.665 |
| Day Low | 6.1283 |
| Debt To Equity | 76.231 |
| Display Name | eXoZymes |
| Earnings Call Timestamp End | 1,747,083,600 |
| Earnings Call Timestamp Start | 1,747,083,600 |
| Earnings Timestamp End | 1,747,047,540 |
| Earnings Timestamp Start | 1,747,047,540 |
| Ebitda | -9,861,112 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -5.449 |
| Enterprise Value | 53,731,500 |
| Eps Trailing Twelve Months | -1.15 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 8.82696 |
| Fifty Day Average Change | -2.4569597 |
| Fifty Day Average Change Percent | -0.27834722 |
| Fifty Two Week Change Percent | -28.96453 |
| Fifty Two Week High | 18.4 |
| Fifty Two Week High Change | -12.03 |
| Fifty Two Week High Change Percent | -0.65380436 |
| Fifty Two Week Low | 6.1283 |
| Fifty Two Week Low Change | 0.2416997 |
| Fifty Two Week Low Change Percent | 0.039439924 |
| Fifty Two Week Range | 6.1283 - 18.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,731,508,200,000 |
| Float Shares | 6,319,901 |
| Free Cashflow | -3,776,458 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 32 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.64533997 |
| Held Percent Institutions | 0.00678 |
| Implied Shares Outstanding | 9,281,359 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California. |
| Long Name | eXoZymes, Inc. |
| Market | us_market |
| Market Cap | 59,122,256 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1687004448 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-09 |
| Net Income To Common | -9,672,560 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 63,577,309 |
| Open | 7.665 |
| Operating Cashflow | -6,892,948 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 626 415 1488 |
| Post Market Change | 0.010000229 |
| Post Market Change Percent | 0.15698947 |
| Post Market Price | 6.38 |
| Post Market Time | 1,783,973,404 |
| Prev Name | Invizyne Technologies, Inc. |
| Previous Close | 6.85 |
| Price Hint | 2 |
| Price To Book | 35.388885 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.104 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.48000002 |
| Regular Market Change Percent | -7.0072994 |
| Regular Market Day High | 7.665 |
| Regular Market Day Low | 6.1283 |
| Regular Market Day Range | 6.1283 - 7.665 |
| Regular Market Open | 7.665 |
| Regular Market Previous Close | 6.85 |
| Regular Market Price | 6.37 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 12,873 |
| Return On Assets | -0.81641996 |
| Return On Equity | -1.8583701 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 9,281,359 |
| Shares Percent Shares Out | 0.0017 |
| Shares Short | 15,720 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 15,037 |
| Short Name | eXoZymes Inc. |
| Short Percent Of Float | 0.0032 |
| Short Ratio | 1.71 |
| Source Interval | 15 |
| State | CA |
| Symbol | EXOZ |
| Total Cash | 1,444,562 |
| Total Cash Per Share | 0.17 |
| Total Debt | 1,164,882 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.15 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 10.847165 |
| Two Hundred Day Average Change | -4.477165 |
| Two Hundred Day Average Change Percent | -0.4127498 |
| Type Disp | Equity |
| Volume | 12,873 |
| Website | https://www.exozymes.com |
| Zip | 91,016 |